In FY16, the top five — Sun Pharma, Dr Reddy’s, Lupin, Aurobindo and Cipla — ran up a total bill of Rs 3,497 crore in legal and professiona...

The deal closure, that involved approvals from the US regulatory agencies, will see Cipla vault its sales from that market to around $400 m...

In an email response seeking comment, PuraCap said its complaint was publicly available at the US District Court for the Southern District ...

The S&P BSE Sensex recouped losses after falling as much as 133 points in opening trade on Wednesday following muted trend seen in other As...

Indian markets are expected to trade in a range. Here is a list of twelve stocks which are likely to remain in focus today.

Acquisitions of two companies in the US will help Cipla increase its foothold in the market and has made analysts bullish on the counter.

We have had a good beginning in the US since our ‘go live’ in January 2015 and we expect to continue our growth trajectory there.

India Ratings & Research today said Cipla's ratings are unlikely to be affected by the recent cash-rich acquisitions of two US-based compan...

Cipla said the group, through its subsidiary Camber Pharmaceuticals Inc., will continue to strengthen its operations in the US.

Cipla shares climbed over 3% in morning trade after the company said its UK-based subsidiary, Cipla EU, will acquire two US-based companies.